Advanced vaccinology training globally: Update and impact of the COVID-19 crisis.
Courses
Education
Global
Vaccines
Vaccinology
Journal
Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899
Informations de publication
Date de publication:
16 09 2022
16 09 2022
Historique:
received:
09
03
2022
revised:
07
07
2022
accepted:
15
08
2022
pubmed:
28
8
2022
medline:
14
9
2022
entrez:
27
8
2022
Statut:
ppublish
Résumé
The rapid development of innovations and new technologies, the focus on the life-course approach to immunization and equity, and the prevalent hesitancy towards vaccines requires immunization staff to be well-trained and updated regularly in order to deliver quality immunization services to the public. The need for advanced vaccinology training is therefore paramount. In preparation for a second Global Workshop on Advanced Vaccinology Training that took place in March 2022, this paper presents the results of a survey aiming to provide a thorough update of a landscape analysis on advanced vaccinology courses conducted in 2018 and a look at the impact of the COVID-19 crisis. Thirty-three course organizers responded to a survey to provide information on their respective course. Of those, 17 courses are short courses, 11 post-graduate courses and 5 are Master level courses. Most courses are organized on an annual basis. Even though some courses were not sustained overtime, the number of courses has been increasing during the last few years, and at least one vaccinology course is now being offered in each WHO region. Although the training capacity has increased tremendously, the need still exceeds the capacity and many courses have way more applicants than they can select. The most frequent challenges reported included sustainable funding and identifying faculty. The COVID-19 pandemic impacted the delivery of several vaccinology courses, which have been postponed or reformatted to an online or hybrid training event. An e-portal of the global collaboration has been established to facilitate communication between the different courses and to assist future course participants to identify the most suitable course for their needs.
Identifiants
pubmed: 36030127
pii: S0264-410X(22)01006-4
doi: 10.1016/j.vaccine.2022.08.029
pmc: PMC9393177
pii:
doi:
Substances chimiques
Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
5683-5690Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
Copyright © 2022. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Vaccine. 2019 May 16;37(22):2871-2881
pubmed: 30898392
Front Immunol. 2018 May 24;9:1134
pubmed: 29881385
Vaccine. 2013 Apr 18;31 Suppl 2:B5-31
pubmed: 23734366
Vaccine. 2020 Jun 19;38(30):4664-4670
pubmed: 32475535
Vaccine. 2019 Aug 14;37(35):4928-4936
pubmed: 31326253
Vaccine. 2012 Aug 10;30(37):5491-5
pubmed: 22766245
J Contin Educ Health Prof. 2009 Winter;29(1):1-15
pubmed: 19288562
BMJ Glob Health. 2019 Sep 20;4(5):e001363
pubmed: 31637022
Expert Rev Vaccines. 2010 Sep;9(9):1023-6
pubmed: 20822345